Literature DB >> 9925653

Lipoproteins inhibit macrophage activation by lipoteichoic acid.

C Grunfeld1, M Marshall, J K Shigenaga, A H Moser, P Tobias, K R Feingold.   

Abstract

Regulation of lipid metabolism during infection is thought to be part of host defense, as lipoproteins neutralize endotoxin (LPS) and viruses. Gram-positive infections also induce disturbances in lipid metabolism. Therefore, we investigated whether lipoproteins could inhibit the toxic effects of lipoteichoic acid (LTA), a fragment of gram-positive bacteria. LTA activated RAW264.7 macrophage cells, stimulating production of tumor necrosis factor (TNF) in a dose-dependent matter, but produced less TNF than that seen after LPS activation. High density (HDL) or low density lipoprotein (LDL) alone inhibited the ability of LPS to stimulate TNF production, but had little effect on the activation by LTA. When a maximally effective dose of LTA was mixed with lipoproteins and 10% lipoprotein-depleted plasma (LPDP), the ability of LTA to stimulate macrophage production of TNF was inhibited. HDL, LDL, and the synthetic particle, Soyacal, when mixed with LPDP, were able to inhibit the ability of LTA to activate macrophages. Lipopolysaccharide-binding protein (LBP) substituted for LPDP in catalyzing lipoprotein neutralization of LTA by HDL. Antibody to LBP inhibited the ability of LPDP to induce LTA neutralization by HDL.Thus, lipoproteins can prevent macrophage activation by fragments from both gram-positive and gram-negative microorganisms.-Grunfeld, C., M. Marshall, J. K. Shigenaga, A. H. Moser, P. Tobias, and K. R. Feingold. Lipoproteins inhibit macrophage activation by lipoteichoic acid.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9925653

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  43 in total

1.  TLR4, NOD1 and NOD2 mediate immune recognition of putative newly identified periodontal pathogens.

Authors:  Julie Marchesan; Yizu Jiao; Riley A Schaff; Jie Hao; Thiago Morelli; Janet S Kinney; Elizabeth Gerow; Rachel Sheridan; Vinicius Rodrigues; Bruce J Paster; Naohiro Inohara; William V Giannobile
Journal:  Mol Oral Microbiol       Date:  2015-09-10       Impact factor: 3.563

Review 2.  Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond.

Authors:  Amy S Shah; Lirong Tan; Jason Lu Long; W Sean Davidson
Journal:  J Lipid Res       Date:  2013-02-24       Impact factor: 5.922

3.  The Scl1 of M41-type group A Streptococcus binds the high-density lipoprotein.

Authors:  Yumin Gao; Chunwei Liang; Ruidong Zhao; Slawomir Lukomski; Runlin Han
Journal:  FEMS Microbiol Lett       Date:  2010-05-14       Impact factor: 2.742

Review 4.  Animal models and the tumor microenvironment: studies of tumor-host symbiosis.

Authors:  Daniel Lindner
Journal:  Semin Oncol       Date:  2014-02-14       Impact factor: 4.929

Review 5.  Lipid testing in infectious diseases: possible role in diagnosis and prognosis.

Authors:  Sebastian Filippas-Ntekouan; Evangelos Liberopoulos; Moses Elisaf
Journal:  Infection       Date:  2017-05-08       Impact factor: 3.553

6.  Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations.

Authors:  Siegfried Morath; Armin Geyer; Ingo Spreitzer; Corinna Hermann; Thomas Hartung
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 7.  The structure and function of serum opacity factor: a unique streptococcal virulence determinant that targets high-density lipoproteins.

Authors:  Harry S Courtney; Henry J Pownall
Journal:  J Biomed Biotechnol       Date:  2010-07-08

8.  Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins.

Authors:  Sylvette Bas; Richard W James; Cem Gabay
Journal:  BMC Immunol       Date:  2010-09-16       Impact factor: 3.615

Review 9.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

10.  LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction.

Authors:  A C Vreugdenhil; A M Snoek; C van 't Veer; J W Greve; W A Buurman
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.